Fmr LLC Allogene Therapeutics, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 983,001 shares of ALLO stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

983,001

Previous 7,394,162 86.71%

Holding current value

$1.25 Million

Previous $10.8 Million 89.72%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.95 - $1.7 $6.09 Million - $10.9 Million	-6,411,161 Reduced 86.71%	983,001 $1.11 Million
Q1 2025 May 12, 2025	SELL	$1.4 - $2.84 $22.9 Million - $46.5 Million	-16,377,833 Reduced 68.9%	7,394,162 $10.8 Million
Q4 2024 Feb 13, 2025	SELL	$1.84 - $3.22 $11.5 Million - $20.1 Million	-6,254,961 Reduced 20.83%	23,771,995 $50.6 Million
Q3 2024 Nov 13, 2024	SELL	$2.08 - $3.5 $2.56 Million - $4.31 Million	-1,230,644 Reduced 3.94%	30,026,956 $84.1 Million
Q2 2024 Aug 13, 2024	BUY	$2.23 - $4.38 $13.1 Million - $25.8 Million	5,893,802 Added 23.24%	31,257,600 $72.8 Million
Q1 2024 May 13, 2024	BUY	$2.92 - $5.63 $357,113 - $688,543	122,299 Added 0.48%	25,363,798 $113 Million
Q4 2023 Feb 13, 2024	BUY	$2.28 - $3.5 $222,455 - $341,488	97,568 Added 0.39%	25,241,499 $81 Million
Q3 2023 Nov 13, 2023	BUY	$3.17 - $5.96 $716,343 - $1.35 Million	225,976 Added 0.91%	25,143,931 $79.7 Million
Q2 2023 Aug 11, 2023	BUY	$4.53 - $6.74 $107 Million - $159 Million	23,548,101 Added 1719.02%	24,917,955 $124 Million
Q1 2023 May 11, 2023	SELL	$4.92 - $8.21 $924,354 - $1.54 Million	-187,877 Reduced 12.06%	1,369,854 $6.77 Million
Q4 2022 Feb 13, 2023	BUY	$5.62 - $11.11 $1.84 Million - $3.64 Million	328,073 Added 26.68%	1,557,731 $9.8 Million
Q3 2022 Nov 10, 2022	SELL	$10.32 - $17.28 $941,555 - $1.58 Million	-91,236 Reduced 6.91%	1,229,658 $13.3 Million
Q2 2022 Aug 12, 2022	BUY	$6.78 - $12.28 $1.34 Million - $2.42 Million	197,226 Added 17.55%	1,320,894 $15.1 Million
Q1 2022 May 13, 2022	SELL	$7.65 - $15.29 $5.75 Million - $11.5 Million	-751,808 Reduced 40.09%	1,123,668 $10.2 Million
Q4 2021 Feb 14, 2022	BUY	$13.13 - $24.52 $12.7 Million - $23.7 Million	966,226 Added 106.27%	1,875,476 $28 Million
Q3 2021 Nov 15, 2021	BUY	$21.01 - $27.64 $5.16 Million - $6.78 Million	245,401 Added 36.97%	909,250 $23.4 Million
Q2 2021 Aug 13, 2021	BUY	$23.49 - $35.8 $15.6 Million - $23.8 Million	663,849 New	663,849 $17.3 Million

Others Institutions Holding ALLO

# of Institutions

170

Shares Held

162M

Call Options Held

146K

Put Options Held

97.1K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $183M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account